Integral Health Asset Management’s DexCom DXCM Stock Holding History

Integral Health Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11M	Sell	175,000 -325,000	-65%	-$22.6M	0.53%	51
2025 Q4	$33.2M	Buy	+500,000	New	+$32.3M	1.65%	15
2025 Q3	–	Sell	-200,000	Closed	-$17.5M	–	82
2025 Q2	$17.5M	Buy	200,000 +100,000	+100%	+$7.84M	1.6%	20
2025 Q1	$6.83M	Sell	100,000 -50,000	-33%	-$4.08M	0.73%	41
2024 Q4	$11.7M	Buy	150,000 +30,000	+25%	+$2.22M	0.99%	35
2024 Q3	$8.04M	Buy	+120,000	New	+$9.85M	0.91%	30
2024 Q2	–	Sell	-100,000	Closed	-$13.9M	–	85
2024 Q1	$13.9M	Sell	100,000 -25,000	-20%	-$3.14M	1.29%	32
2023 Q4	$15.5M	Sell	125,000 -50,000	-29%	-$5.11M	2.11%	13
2023 Q3	$16.3M	Buy	+175,000	New	+$19.7M	2.26%	16
2022 Q3	–	Sell	-166,991	Closed	-$12.4M	–	69
2022 Q2	$12.4M	Buy	+166,991	New	+$15.2M	2.56%	14
2021 Q4	–	Sell	-40,000	Closed	-$5.47M	–	75
2021 Q3	$5.47M	Buy	+40,000	New	+$5.04M	1.57%	23
2020 Q4	–	Sell	-24,000	Closed	-$2.47M	–	65
2020 Q3	$2.47M	Sell	24,000 -36,000	-60%	-$3.76M	0.76%	50
2020 Q2	$6.08M	Buy	+60,000	New	+$5.37M	1.82%	23
2020 Q1	–	Sell	-240,000	Closed	-$13.1M	–	62
2019 Q4	$13.1M	Buy	+240,000	New	+$11.4M	5.11%	2

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Integral Health Asset Management's DXCM Position: Q1 2026 in Review

Integral Health Asset Management reduced its DexCom (DXCM) stake by 65% in Q1 2026, selling an estimated $22.6M and leaving 175,000 shares worth $11M. The position accounts for 0.53% of the portfolio, ranked #51.

Integral Health Asset Management first reported a position in DXCM in Q4 2019 and has held it in 14 quarters since. The position peaked at $33.2M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Integral Health Asset Management held 175,000 shares of DexCom worth $11M as of Q1 2026.
Integral Health Asset Management sold 325,000 DexCom shares in Q1 2026, an estimated $22.6M.
DexCom made up 0.53% of Integral Health Asset Management's portfolio in Q1 2026, its #51 holding.
Integral Health Asset Management first reported a position in DexCom in Q4 2019 and has held it in 14 quarters since.
Integral Health Asset Management's DexCom position peaked at $33.2M in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.